Table 1.
Comparison of N-glycosylation sites between spike glycoproteins of 2019-nCoV and SARS-CoV strains
N-glycosylation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2019-nCoV | SARS-CoV | ||||||||||
Position (NetNGlyc 1.0) agreement result | Position (N-GlyDE) | Sites | Potential | Jury agreement | N-Glyc Result | Position (NetNGlyc 1.0) agreement result | Position (N-GlyDE) | Sites | Potential | Jury agreement | N-Glyc Result |
– | – | – | – | – | – | 29 | 29 | NYTQ | 0.7751 | (9/9) | +++ |
61 | 61 | NVTW | 0.7820 | (9/9) | +++ | 65 | 65 | NVTG | 0.8091 | (9/9) | +++ |
234 | 234 | NITR | 0.7613 | (9/9) | +++ | 227 | 227 | NITN | 0.7518 | (9/9) | +++ |
74 | 74 | NGTK | 0.7192 | (9/9) | ++ | 119 | 119 | NSTN | 0.7039 | (9/9) | ++ |
282 | 282 | NGTI | 0.7378 | (9/9) | ++ | 269 | 269 | NGTI | 0.6910 | (9/9) | ++ |
616 | 616 | NCTE | 0.7163 | (9/9) | ++ | 318 | 318 | NITN | 0.6413 | (9/9) | ++ |
717 | 717 | NFTI | 0.6426 | (9/9) | ++ | 602 | 602 | NCTD | 0.6916 | (9/9) | ++ |
1194 | 1194 | NESL | 0.6791 | (9/9) | ++ | 783 | 783 | NFSQ | 0.6260 | (9/9) | ++ |
17 | 17 | NLTT | 0.6606 | (8/9) | + | 1176 | 1176 | NESL | 0.6794 | (9/9) | ++ |
122 | 122 | NATN | 0.6781 | (8/9) | + | 73 | 73 | NHTF | 0.5303 | (4/9) | + |
149 | 149 | NKSW | 0.6318 | (7/9) | + | 109 | 109 | NKSQ | 0.6080 | (7/9) | + |
165 | 165 | NCTF | 0.6220 | (8/9) | + | 158 | 158 | NCTF | 0.5808 | (7/9) | + |
331 | 331 | NITN | 0.5970 | (7/9) | + | 330 | 330 | NATK | 0.6063 | (8/9) | + |
343 | 343 | NATR | 0.5671 | (8/9) | + | 357 | 357 | NSTS | 0.6836 | (8/9) | + |
603 | 603 | NTSN | 0.5783 | (6/9) | + | 589 | 589 | NASS | 0.5777 | (6/9) | + |
801 | 801 | NFSQ | 0.6146 | (8/9) | + | 699 | 699 | NFSI | 0.5356 | (7/9) | + |
1098 | 1098 | NGTH | 0.5496 | (5/9) | + | 1080 | 1080 | NGTS | 0.5806 | (7/9) | + |
1134 | 1134 | NNTV | 0.5800 | (6/9) | + | 1116 | 1116 | NNTV | 0.5107 | (5/9) | + |
The table shows a comparison of predicted N-glycosylation sites in Spike glycoprotein of Wuhan-Hu-1–2019 novel coronavirus (2019-nCoV) and SARS coronavirus-2003 (SARS-CoV) strains. N-glycosylation potential (0.5) was taken as cutoff. The N-glycosylation sites were determined by NetNGlyc 1.0 [20] and validated by N-GlyDE server [21]
*Italics indicates the differences between N-glycosylation sites between the two Spike glycoproteins